Stowe David F, Gadicherla Ashish K, Zhou Yifan, Aldakkak Mohammed, Cheng Qunli, Kwok Wai-Meng, Jiang Ming Tao, Heisner James S, Yang Meiying, Camara Amadou K S
Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI, USA.
Biochim Biophys Acta. 2013 Feb;1828(2):427-42. doi: 10.1016/j.bbamem.2012.08.031. Epub 2012 Sep 8.
We tested if small conductance, Ca(2+)-sensitive K(+) channels (SK(Ca)) precondition hearts against ischemia reperfusion (IR) injury by improving mitochondrial (m) bioenergetics, if O(2)-derived free radicals are required to initiate protection via SK(Ca) channels, and, importantly, if SK(Ca) channels are present in cardiac cell inner mitochondrial membrane (IMM). NADH and FAD, superoxide (O(2)(-)), and m[Ca(2+)] were measured in guinea pig isolated hearts by fluorescence spectrophotometry. SK(Ca) and IK(Ca) channel opener DCEBIO (DCEB) was given for 10 min and ended 20 min before IR. Either TBAP, a dismutator of O(2)()(-), NS8593, an antagonist of SK(Ca) isoforms, or other K(Ca) and K(ATP) channel antagonists, were given before DCEB and before ischemia. DCEB treatment resulted in a 2-fold increase in LV pressure on reperfusion and a 2.5 fold decrease in infarct size vs. non-treated hearts associated with reduced O(2)(-) and m[Ca(2+)], and more normalized NADH and FAD during IR. Only NS8593 and TBAP antagonized protection by DCEB. Localization of SK(Ca) channels to mitochondria and IMM was evidenced by a) identification of purified mSK(Ca) protein by Western blotting, immuno-histochemical staining, confocal microscopy, and immuno-gold electron microscopy, b) 2-D gel electrophoresis and mass spectroscopy of IMM protein, c) [Ca(2+)]-dependence of mSK(Ca) channels in planar lipid bilayers, and d) matrix K(+) influx induced by DCEB and blocked by SK(Ca) antagonist UCL1684. This study shows that 1) SK(Ca) channels are located and functional in IMM, 2) mSK(Ca) channel opening by DCEB leads to protection that is O(2)(-) dependent, and 3) protection by DCEB is evident beginning during ischemia.
我们测试了小电导钙敏感钾通道(SK(Ca))是否通过改善线粒体生物能量学来预处理心脏以抵抗缺血再灌注(IR)损伤,是否需要氧衍生的自由基通过SK(Ca)通道启动保护作用,以及重要的是,心脏细胞线粒体内膜(IMM)中是否存在SK(Ca)通道。通过荧光分光光度法在豚鼠离体心脏中测量烟酰胺腺嘌呤二核苷酸(NADH)、黄素腺嘌呤二核苷酸(FAD)、超氧化物(O(2)(-))和线粒体钙浓度(m[Ca(2+)])。在IR前20分钟给予SK(Ca)和钙激活钾通道(IK(Ca))开放剂双氯苯醚菊酯(DCEB)10分钟。在给予DCEB之前和缺血之前,给予超氧化物歧化酶(TBAP,一种O(2)(-)的歧化剂)、SK(Ca)亚型拮抗剂NS8593或其他钾钙通道(K(Ca))和钾离子ATP通道(K(ATP))拮抗剂。与未处理的心脏相比,DCEB处理导致再灌注时左心室压力增加2倍,梗死面积减少2.5倍,同时在IR期间O(2)(-)和m[Ca(2+)]减少,NADH和FAD更接近正常水平。只有NS8593和TBAP拮抗DCEB的保护作用。通过以下方法证明了SK(Ca)通道在线粒体和IMM中的定位:a)通过蛋白质免疫印迹、免疫组织化学染色、共聚焦显微镜和免疫金电子显微镜鉴定纯化的线粒体SK(Ca)蛋白;b)IMM蛋白的二维凝胶电泳和质谱分析;c)平面脂质双层中线粒体SK(Ca)通道对[Ca(2+)]的依赖性;d)DCEB诱导的基质钾内流以及被SK(Ca)拮抗剂UCL1684阻断。本研究表明:1)SK(Ca)通道定位于IMM且具有功能;2)DCEB开放线粒体SK(Ca)通道导致的保护作用依赖于O(2)(-);3)DCEB的保护作用在缺血期间就已明显显现。